PMC:7175914 / 21169-21589 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"134","span":{"begin":33,"end":71},"obj":"Gene"},{"id":"135","span":{"begin":111,"end":114},"obj":"Chemical"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"For the other three time points, Sce 1: (q 1, q 2) = (0q 1  * , 0q 2  *) increased the MVCCC and prolonged the DDE with the values of 1430 at 123 days (i.e. May 28, 2020), 1416 at 115 days (i.e. May 20, 2020) and 1409 at 112 days (i.e. May 17, 2020) (STable 2). The disease variations of the other scenarios are agreement with the baseline results which indicates the weak impacts of these scenarios (Fig. 5A, STable 2)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T18","span":{"begin":111,"end":114},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_16598"}],"text":"For the other three time points, Sce 1: (q 1, q 2) = (0q 1  * , 0q 2  *) increased the MVCCC and prolonged the DDE with the values of 1430 at 123 days (i.e. May 28, 2020), 1416 at 115 days (i.e. May 20, 2020) and 1409 at 112 days (i.e. May 17, 2020) (STable 2). The disease variations of the other scenarios are agreement with the baseline results which indicates the weak impacts of these scenarios (Fig. 5A, STable 2)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T149","span":{"begin":0,"end":261},"obj":"Sentence"},{"id":"T150","span":{"begin":262,"end":420},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For the other three time points, Sce 1: (q 1, q 2) = (0q 1  * , 0q 2  *) increased the MVCCC and prolonged the DDE with the values of 1430 at 123 days (i.e. May 28, 2020), 1416 at 115 days (i.e. May 20, 2020) and 1409 at 112 days (i.e. May 17, 2020) (STable 2). The disease variations of the other scenarios are agreement with the baseline results which indicates the weak impacts of these scenarios (Fig. 5A, STable 2)."}